US Stocks

Nkarta, Inc.

Nkarta is a biopharmaceutical company that creates cell therapies for cancer treatment through chimeric antigen receptor technology. The two leading product candidates for the company treat myeloid leukemia and B cell malignancies. They have a research collaboration with CRISPR Therapeutics AG, and their headquarters is in South San Francisco, California.